Ranitidine
Product Images NDC 10544-438

3 FDA label images from Blenheim Pharmacal, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 10544-438). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (342c8499 74fe 4f3b 97c0 F144244b2f8e 01)

Structure (342c8499 74fe 4f3b 97c0 F144244b2f8e 01)
Chemical structure of Ranitidine hydrochloride, showing the molecular arrangement including a furan ring, nitro group, and tertiary amine with associated hydrochloride.*
FDA Label Image

Logo (342c8499 74fe 4f3b 97c0 F144244b2f8e 02)

FDA Label Image

Label (Label Ranitidine Tabs 150mg Bpi(10544 438 60) Glenmark(68462 248 05) Rev1)

Label (Label Ranitidine Tabs 150mg Bpi(10544 438 60) Glenmark(68462 248 05) Rev1)
Ranitidine Tablets USP 150mg bottle label from Blenheim Pharmacal, Inc. The label indicates a quantity of 60 tablets, Rx only, with storage instructions to keep in a controlled room temperature environment and away from light. It includes NDC 10544-438-60 and manufacturing lot and expiration date placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.